University of Florida College of Nursing

Slides:



Advertisements
Similar presentations
Phase O Trials: Ethical Considerations Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman Institute.
Advertisements

Fundamentals of IRB Review. Regulatory Role of the IRB Authority to approve, require modifications in (to secure approval), or disapprove all research.
Evaluating Risk 1 IRB CELT Presentation Colleen Donaldson – IRB Administrator Julie Wilkens – IRB Coordinator.
How You Can Be an Advocate for Clinical Trials in Your Community.
Thematic Analysis of Cardiac Care Patient Explanations for Declining Contribution to a Genomic Research-based Biobank.
Community-Based Participatory Research (CBPR) to Reduce Women’s Health Disparities thru TANF Study Shawn M. Kneipp, ARNP, Ph.D. University of Florida College.
SCHEN SCC-CSI MUSC Walter Limehouse MD MA MUSC Emergency Medicine.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
Perceptions of Medicaid Beneficiaries Regarding the Usefulness of Accessing Personal Health Information and Services through a Patient Internet Portal.
Staying the Course: Facility and Profession Retention among Nursing Assistants in Nursing Homes Sally C. Stearns, PhD Laura D’Arcy, MPA The University.
Introduction Smoking and Social Networks Joseph R. Pruis, Student Research Collaborator, Rosemary A. Jadack, PhD, RN, Professor Department Of Nursing,
May I have your permission please? The consent process: What, Where, When, Who and Why Valerie Smith OHRP IRB Program Manager
Module 3: Informed Consent. This training session contains information regarding: Documenting consent Documenting consent Conducting informed consent.
University of North Carolina at Greensboro Protecting Research Participants.
HUMAN SUBJECTS PROTECTION PROGRAM Office Location: 1350 N. Vine Ave. (one block west of Cherry Ave. & three blocks north of Speedway) PO Box Phone:
How to Successfully Apply to the IRB Richard Gordin, IRB Chair True Rubal, Administrator / Director For the Protection of Human Participants in Research.
IRB BASICS: Issues in Ethics and Human Subject Protections Prepared by Ed Merrill Department of Psychology November 12, 2009.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
ProTECT III Community Consultation Study Neal W Dickert, MD, PhD, Victoria Mah, MPH, Michelle H Biros, MD, Deneil Harney, MPH, MSW, Robert E Silbergleit,
Ethical Concerns (Informed Consent) By MaryKate O’Connor.
Conflicts of Interest in Research : Perspective of the IRB Human Subject Protections Monika S. Markowitz, PhD Director, Office of Research Compliance and.
Certificate IV in Project Management Project Management Ethics & Code of Conduct Course Number Qualification Code BSB41507.
Research ethics.
Adolescent Vaccination: Taking It to the Schools Immunization Site Preferences Among Primarily Hispanic Middle School Parents Amy B. Middleman, MD, MSEd,
T Relationships do matter: Understanding how nurse-physician relationships can impact patient care outcomes Sandra L. Siedlecki PhD RN CNS.
Sharing time and talents: Building caring communities
Attachment style and condom use across and within dating relationships
Back to Basics – Approval Criteria
World Health Organization
COCE Institutional Review Board Academic Spotlight
Thank you for being here today.
University of Akron – Akron, OH For further information
University of Central Florida Office of Research & Commercialization
Taking informed consent and withdrawal
Thomas White, Stephen F. Duncan, and Jeremy B. Yorgason
Emma Kientz, MS, APRN-CNS, CNE
Clinicaltrials.gov Update
FDA’s IDE Decisions and Communications
Assisting with the Nursing Process
CBPR to Reduce Women’s Health Disparities thru TANF Study: Focus Group and Survey Findings to Redesign a Clinical Health Screening Questionnaire Shawn.
Diploma of Project Management Project Management Ethics & Code of Conduct Course Number Qualification Code BSB51507.
Research with human participants at Carnegie Mellon University
World Health Organization
Isabel C. Scarinci, PhD, MPH University of Alabama at Birmingham
Effects of Educating URI General Education Students on Physical Activity, Exercise, and Disease Prevention and Maintenance Julie Gastall, Department.
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
Participant Characteristics
University of Central Florida Office of Research & Commercialization
© 2016 The McGraw-Hill Companies, Inc.
Tourism Marketing for small businesses
Supporting Students with Complex Needs
Youngwummin: Ethics and Data Collection Methods
IRB The purpose of IRB is to ensure the rights of research subjects are protected In accordance with the ethical standards of the U.S. Department of Health.
Analysis of Parental Vaccine Beliefs by Child’s School Type
Does My Project Require HRPP/IRB Review?
Consent Training Module
Planning Instruction Component 3: Session 4
Elements of a Successful Informed Consent
Revised Common Rule: Informed Consent Changes
Consent, throughout the Early Help Journey
The Center for Nursing Research Ochsner Health System December 2015
Child Health Evaluation and Research Unit
Implementing the Child Outcomes Summary Process: Challenges, strategies, and benefits July, 2011 Welcome to a presentation on implementation issues.
Population Assessment Online Presentation Presented By:
Office of Research Integrity and Protections
Treatment Research Institute
Implementing the Child Outcomes Summary Process: Challenges, strategies, and benefits July, 2011 Welcome to a presentation on implementation issues.
New Mexico Census outreach message/messenger testing survey
New Mexico Census outreach message/messenger testing survey
Influenza Vaccine Delay From the Primary Care Physician’s Perspective
Presentation transcript:

University of Florida College of Nursing Perceptions, Delivery, and Understanding of the Informed Consent Process Among Women Participating in a CBPR Study of Welfare Policy and Health Shawn M. Kneipp, PhD, ARNP Barbara Lutz, PhD, RN Deirdra Means Michelle E. Galin, RN, BSN University of Florida College of Nursing NIH/NINR #R01 NR009406-01

Acknowledgements Shawn M. Kneipp, PhD, ARNP – PI University of Florida College of Nursing Barbara Lutz, PhD, RN – Co-I Deidre Pereira, PhD – Co-I University of Florida College of Public Health & Health Professions Allyson Hall, PhD – Co-I Joan Flocks, JD – Consultant University of Florida College of Law Linda Beeber, PhD, RN – Consultant University of North Carolina, Chapel Hill School of Nursing Cynthia Allen Study Coordinator Deirdra Means Research Assistant Michelle M. Galin, BSN, MPH Student Intervention Public Health Nurse Community Advisory Group Members

Study Purpose The purpose of this study was to better understand the following from a sample of low-income women that recently participated in a study using a “community-based participatory research” (CBPR) approach: why they chose to enroll in the study, what they recall from the informed consent process, what they learned about research during participation in the study, and what aspects of the focus group studies are most likely to engage them in future studies.

Study Sample/Context Women receiving TANF/public assistance benefits in Welfare Transition Program (WTP) Participated in focus groups for larger study Focus groups held on-site at WTP High potential for coercion / not understanding participation is voluntary Lack of trust in agents working on behalf of WTP

Study Sample/Design n=61 women who participated in 10 CBPR Focus Groups from Jan.2006 – May 2006 Exempt IRB approval May 2006 Mailed survey/questionnaire 1st Mailing: June 2006 (n=60) 2nd Mailing/Reminder: July 2006(with <75% response rate from 1st mail out) Questionnaire: Brief – 3 pages $5.00 Gift certificate included w/ 1st mail out

Response Rate n=29 responded w/ 1st mail out Additional n=6 responded w/ 2nd reminder mail out Additional 10% response rate Total of n=35 out of 60 responded 58% of sample responded

Sample Demographics

Sample Demographics Age 31.8 8.3 19 – 52 Race AA/Black 57% White 40% Characteristic % Mean SD Min - Max Age 31.8 8.3 19 – 52 Race AA/Black 57% White 40% Ethnicity Hispanic 21% # of Children 2.4 1.2 1 - 6

Sample Demographics (2) Characteristic % Mean SD Min - Max Education Level < 12th Grade 9% HS Dip/GED 57% Some College 31% Marital Status Single/Div/Wid 89% Married 11%

Sample Representation Focus Grp Sample (61) FG Views Sample (35) Characteristic % Mean Race: AA/Black 69% 57% White 25% 40% Ethnicity: Hispanic 7% 21% Educ: <12th Grade 9% HS Dip/GED Some Coll. 39% 31% Coll Degree 10% 3% Wilcoxen rank-sum of factors describing why participated in FG study = no significant differences by race except for: ‘Way the RA talked to me.’ White women ranked as more important than AA women (p=.047)

Informed Consent Process Questions Anecdotal observations in prior studies and CBPR focus groups suggested informed consent played small role in decision-making to participate in study. Unclear whether content of consent well understood. Absence of literature regarding preferences for, perceptions of, and/or understanding of consent by lower SES women who participate in research.

Questions About Informed Consent Focused on: Knowledge/understanding/retention of IC content Weight in decision-making about whether to enroll Interest in/review of consent after participation Prior knowledge of past research participant abuses Trust in researchers to follow what was outlined in the consent Preferences for consent process.

Understanding of Informed Consent 100% correctly selected “True” to the following: a. The informed consent tells you about how the researchers will protect your confidentiality and personal information. The informed consent stated being in the study was completely my choice, or voluntary. c. Being in the focus group was not part of the Welfare Transition Program.

Weight of Decision-Making About Whether to Enroll in Study 100% of women enrolled in the study following review of IC

Review of Informed Consent After Focus Group Completed

Prior Knowledge of Research Participant Abuses

Comfort With / Trust in Researchers Regarding Informed Consent

Preferences for Consent Process

Open-Ended Questions & Narratives

“Please tell us what you learned about research by participating in our CBPR focus group study” . . .

“I learned that research does deal with realistic concerns with everyday people such as myself.” “That this is a good thing, research isn't at all that bad.” “[It] takes a long time to study stuff-its better the way you did it. I hate it when people walking around on the street or a phone call to you to ask questions, you don't even want to talk to them, you all did it right.” “Very long / too long . . . Very complicated.”

Explaining/Understanding of FG Purpose, General Experience

Summary CBPR FGs were a good experience. Women understood informed consent purpose, trusted researchers, and demonstrated interest in consent by reading copy given to them at home. Most important reasons women participated related to identified need/problem, forum to communicate w/ other women in WTP, to help others, and nurse involvement. Narratives suggest understanding of study complexities, and positive perceptions of research participation.

Future Directions Consider similar set of questions for women who participate in the RCT portion of the study for comparison – FG design vs. RCT design. Consider submission for PA-06-368: Research on Ethical Issues in Human Subjects Research. This PA seeks to “assess the extent to which prospective subjects’ decisions about joining research are voluntary . . . explore models of decision-making and the effect of situational and individual characteristics on the decision-making process . . . [and] assess the effects of incentives such as monetary compensation, provision of medical care or other benefits of research on decision-making and perceptions of research by potential or actual participants or study communities” (p.6).

Appendices

Questions About Informed Consent a. The informed consent tells you about how the researchers will protect your confidentiality and personal information. b. The informed consent stated being in the study was completely my choice, or voluntary. c. The information in the informed consent made me question whether I should actually sign up to be in the study. d. While reviewing the informed consent with the study investigator, I felt comfortable enough to ask a question if I wanted to. e. After the focus group, I read through the copy of the informed consent I was given to take home. f. I liked going over the informed consent with the study investigator instead of having to read it all by myself. g. I trusted the researchers would follow all of the procedures outlined in the informed consent. h. Before participating in the focus group, I had previously heard about research participants being treated unfairly in the past.